Genpharmasec Ltd.
|
Income Statement
|
|
You can view the
Income Statement
for the last 5 years.
Market Cap. (Rs.)
|
107.42 Cr.
|
P/BV
|
1.64
|
Book Value (Rs.)
|
1.18
|
52 Week High/Low (Rs.)
|
4/2
|
FV/ML
|
1/1
|
P/E(X)
|
87.39
|
Bookclosure
|
23/07/2024
|
EPS (Rs.)
|
0.02
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Months | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR |
FaceValue | 1.00 | 1.00 |
| | |
| | |
INCOME | | |
Revenue From Operations [Net] | 33.72 | 30.41 |
Total Operating Revenues | 33.72 | 30.41 |
| | |
Other Income | 3.06 | 0.66 |
Total Revenue | 36.78 | 31.06 |
| | |
EXPENSES | | |
Cost Of Materials Consumed | 0.87 | 0.00 |
Purchase Of Stock-In Trade | 28.07 | 23.39 |
Operating And Direct Expenses | 0.00 | 0.01 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 0.61 | 0.83 |
Employee Benefit Expenses | 0.99 | 0.76 |
Finance Costs | 0.43 | 0.41 |
Depreciation And Amortisation Expenses | 0.81 | 0.04 |
Other Expenses | 3.12 | 5.36 |
Total Expenses | 34.90 | 30.81 |
| | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1.88 | 0.25 |
| | |
Profit/Loss Before Tax | 1.88 | 0.25 |
| | |
Tax Expenses-Continued Operations | | |
Current Tax | 0.65 | 0.00 |
Deferred Tax | 0.00 | 0.42 |
Total Tax Expenses | 0.65 | 0.42 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 1.23 | -0.17 |
| | |
Profit/Loss From Continuing Operations | 1.23 | -0.17 |
| | |
Profit/Loss For The Period | 1.23 | -0.17 |
| | |
Minority Interest | 0.00 | 0.04 |
Consolidated Profit/Loss After MI And Associates | 1.23 | -0.13 |
| | |
OTHER INFORMATION | | |
| | |
EARNINGS PER SHARE | | |
Basic EPS (Rs.) | 0.01 | -0.01 |
Diluted EPS (Rs.) | 0.01 | -0.01 |